Martin Holst Lange, executive vice president of development at Novo Nordisk, described REDEFINE 2 as confirming the superior efficacy of CagriSema in people with overweight or obesity and type 2 diabetes and expressed confidence in pursuing regulatory approval
Reference material for research use only
This is probably the million-dollar question
Ellenbroek JH, Tons HA, Westerouen van Meeteren MJ, de Graaf N, Hanegraaf MA, Rabelink TJ, Carlotti F, and de Koning EJ
A 2026 UK review of the histamine-and-wakefulness science, the hippocampal-prefrontal evidence, the anticholinergic-burden & dementia question, why non-drowsy antihistamines come first and why treating the allergy, not a peptide, comes first Read the full review Autoimmune & Cognitive Neuroscience 23 June 2026 Dihexa for Sjgrens Syndrome Brain Fog: Sjgrens Fog, the Ianalumab NEPTUNUS Phase 3, Nipocalimab DAHLIAS & the 2026 UK Review My eyes and mouth are dry but its the fog thats wrecking my life. Up to 500,000 people in the UK live with Sjgrens the second most common autoimmune rheumatic disease after rheumatoid arthritis and brain fog and fatigue routinely rank above dryness for what disrupts daily life, with measurable cognitive impairment in ~4450%
Losing weight can often feel like an uphill battle, especially for those who have tried multiple diets and exercise routines without success